Bioavailability is the rate and extent to which the active ingredient of a drug is absorbed and becomes available at the site of action. It is a critical concept in pharmacokinetics and drug development.
Clinical trials are essential research studies that help determine the effectiveness and safety of new medical interventions, drugs, or treatments.
A period during which a drug is protected from direct competition, granted by regulatory agencies to encourage the development of new treatments.
An in-depth exploration of 'new indications,' a pivotal concept in the medical and pharmaceutical fields, signifying evidence that an existing drug or procedure may have additional applications.
The Orphan Drug Credit is a U.S. tax incentive designed to help pharmaceutical companies manage the high costs associated with developing drugs and treatments for exceedingly rare diseases. This article explores its purpose, benefits, and implications.
